ResMed & Respironics settle eight-year patent battle
This article was originally published in Clinica
Executive Summary
Respiratory technology firms ResMed and Respironics have agreed to settle all of their outstanding patent infringement litigation, some of which dates back to 1995. They will not disclose the terms of the settlement, which covers claims and counterclaims relating to the companies' mask products filed in courts in Pennsylvania and California.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.